Literature DB >> 27026352

Acute kidney injury: Clinical trials in AKI: is the end in sight?

Monica Parks1, Kathleen D Liu2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27026352     DOI: 10.1038/nrneph.2016.35

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  9 in total

1.  Design of clinical trials in AKI: a report from an NIDDK workshop. Trials of patients with sepsis and in selected hospital settings.

Authors:  Bruce A Molitoris; Mark D Okusa; Paul M Palevsky; Lakhmir S Chawla; James S Kaufman; Prasad Devarajan; Robert M Toto; Chi-yuan Hsu; Tom H Greene; Sarah G Faubel; John A Kellum; Ron Wald; Glenn M Chertow; Adeera Levin; Sushrut S Waikar; Patrick T Murray; Chirag R Parikh; Andrew D Shaw; Alan S Go; Vernon M Chinchilli; Kathleen D Liu; Alfred K Cheung; Steven D Weisbord; Ravindra L Mehta; John B Stokes; Aliza M Thompson; B Taylor Thompson; Christof S Westenfelder; James A Tumlin; David G Warnock; Sudhir V Shah; Yining Xie; Emily G Duggan; Paul L Kimmel; Robert A Star
Journal:  Clin J Am Soc Nephrol       Date:  2012-03-22       Impact factor: 8.237

2.  Design of clinical trials in acute kidney injury: a report from an NIDDK workshop--prevention trials.

Authors:  Mark D Okusa; Bruce A Molitoris; Paul M Palevsky; Vernon M Chinchilli; Kathleen D Liu; Alfred K Cheung; Steven D Weisbord; Sarah Faubel; John A Kellum; Ron Wald; Glenn M Chertow; Adeera Levin; Sushrut S Waikar; Patrick T Murray; Chirag R Parikh; Andrew D Shaw; Alan S Go; Lakhmir S Chawla; James S Kaufman; Prasad Devarajan; Robert M Toto; Chi-yuan Hsu; Tom H Greene; Ravindra L Mehta; John B Stokes; Aliza M Thompson; B Taylor Thompson; Christof S Westenfelder; James A Tumlin; David G Warnock; Sudhir V Shah; Yining Xie; Emily G Duggan; Paul L Kimmel; Robert A Star
Journal:  Clin J Am Soc Nephrol       Date:  2012-03-22       Impact factor: 8.237

3.  Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology.

Authors:  Paul M Palevsky; Bruce A Molitoris; Mark D Okusa; Adeera Levin; Sushrut S Waikar; Ron Wald; Glenn M Chertow; Patrick T Murray; Chirag R Parikh; Andrew D Shaw; Alan S Go; Sarah G Faubel; John A Kellum; Vernon M Chinchilli; Kathleen D Liu; Alfred K Cheung; Steven D Weisbord; Lakhmir S Chawla; James S Kaufman; Prasad Devarajan; Robert M Toto; Chi-yuan Hsu; Tom Greene; Ravindra L Mehta; John B Stokes; Aliza M Thompson; B Taylor Thompson; Christof S Westenfelder; James A Tumlin; David G Warnock; Sudhir V Shah; Yining Xie; Emily G Duggan; Paul L Kimmel; Robert A Star
Journal:  Clin J Am Soc Nephrol       Date:  2012-03-22       Impact factor: 8.237

4.  New Strategies for Effective Therapeutics in Critically Ill Patients.

Authors:  Michael A Matthay; Kathleen D Liu
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

5.  Candidate Surrogate End Points for ESRD after AKI.

Authors:  Morgan E Grams; Yingying Sang; Josef Coresh; Shoshana H Ballew; Kunihiro Matsushita; Andrew S Levey; Tom H Greene; Miklos Z Molnar; Zoltan Szabo; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  J Am Soc Nephrol       Date:  2016-02-08       Impact factor: 10.121

6.  The assessment, serial evaluation, and subsequent sequelae of acute kidney injury (ASSESS-AKI) study: design and methods.

Authors:  Alan S Go; Chirag R Parikh; T Alp Ikizler; Steven Coca; Edward D Siew; Vernon M Chinchilli; Chi-Yuan Hsu; Amit X Garg; Michael Zappitelli; Kathleen D Liu; W Brian Reeves; Nasrollah Ghahramani; Prasad Devarajan; Georgia Brown Faulkner; Thida C Tan; Paul L Kimmel; Paul Eggers; John B Stokes
Journal:  BMC Nephrol       Date:  2010-08-27       Impact factor: 2.388

Review 7.  Clinical trials for acute kidney injury: design challenges and possible solutions.

Authors:  Kathleen D Liu; David V Glidden
Journal:  Curr Drug Targets       Date:  2009-12       Impact factor: 3.465

Review 8.  Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial.

Authors:  Steven D Weisbord; Martin Gallagher; James Kaufman; Alan Cass; Chirag R Parikh; Glenn M Chertow; Kendrick A Shunk; Peter A McCullough; Michael J Fine; Maria K Mor; Robert A Lew; Grant D Huang; Todd A Conner; Mary T Brophy; Joanne Lee; Susan Soliva; Paul M Palevsky
Journal:  Clin J Am Soc Nephrol       Date:  2013-05-09       Impact factor: 8.237

9.  Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality.

Authors:  Josef Coresh; Tanvir Chowdhury Turin; Ron T Gansevoort; Andrew S Levey; Kunihiro Matsushita; Yingying Sang; Shoshana H Ballew; Lawrence J Appel; Hisatomi Arima; Steven J Chadban; Massimo Cirillo; Ognjenka Djurdjev; Jamie A Green; Gunnar H Heine; Lesley A Inker; Fujiko Irie; Areef Ishani; Joachim H Ix; Csaba P Kovesdy; Angharad Marks; Takayoshi Ohkubo; Varda Shalev; Anoop Shankar; Chi Pang Wen; Paul E de Jong; Kunitoshi Iseki; Benedicte Stengel
Journal:  JAMA       Date:  2014-06-25       Impact factor: 56.272

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.